Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Current Neuropharmacology(1)
Current Pharmaceutical Design(1)
Drug Discovery Today: Therapeutic Strategies(1)
Expert Opinion on Drug Discovery(1)
Expert Opinion on Investigational Drugs(1)
Área temáticas
Farmacología y terapéutica(6)
Enfermedades(4)
Fisiología humana(4)
Ginecología, obstetricia, pediatría, geriatría(2)
Fisiología y materias afines(1)
Origen
scopus(8)
An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders
ReviewAbstract: Importance of the field: The increase in life expectancy in developed countries has given rise to sePalabras claves:Alzheimer's disease, apoptosis, Neuroprotective drugs, Parkinson's DiseaseAutores:Antoni Camins, Folch J., Junyent F., Pallás M., Sureda F.X., Verdaguer E., Zárate C.B.Fuentes:scopusAntiapoptotic drugs: A therapautic strategy for the prevention of neurodegenerative diseases
ReviewAbstract: The purpose of this review is to discuss potential pathways involved in the pathogenesis of neurodegPalabras claves:Alzheimer's disease, apoptosis, Cyclin-dependent kinases, Glutamate receptors, Neuronal cell death, Neuroprotective drugs. apoptosis, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., Folch J., Junyent F., Pallás M., Pelegrí Gabalda C., Sureda F.X., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusA single dose of pirfenidone attenuates neuronal loss and reduces lipid peroxidation after kainic acid-induced excitotoxicity in the pubescent rat hippocampus
ArticleAbstract: Systemic administration of kainic acid (KA) in rodents triggers limbic seizures following selectivePalabras claves:4-Hydroxynonenal (4-HNE), Kainic Acid Model, Neurodegeneration, neuroprotection, PirfenidoneAutores:Antoni Camins, Armendáriz-Borunda J., Bañuelos-Pineda J., Castro-Torres R.D., Chaparro-Huerta V., Flores-Soto M.E., Orozco-Suárez S.A., Zárate C.B.Fuentes:scopusAging biology: A new frontier for drug discovery
ReviewAbstract: Introduction: The prevalence of age-related pathologies, such as cardiovascular disease, neurodegenePalabras claves:Autores:Antoni Camins, Auladell C., Folch J., Junyent F., Pallás M., Verdaguer E., Zárate C.B.Fuentes:scopusAging control with resveratrol
ReviewAbstract: The prevalence of age-related pathologies such as neurodegenerative disease and diabetes type II hasPalabras claves:Autores:Antoni Camins, Junyent F., Pallás M., Verdaguer E., Zárate C.B.Fuentes:scopusExperimental models for aging and their potential for novel drug discovery
ReviewAbstract: Background: An interesting area of scientific research is the development of potential antiaging druPalabras claves:aging, Heterogeneous mice model, IGF-1, mTOR, Resveratrol, SAMP8, SirtuinsAutores:Antoni Camins, Auladell C., Busquets O., Casadesús G., Ettcheto M., Folch J., Miguel Marin, Olloquequi J., Pallás M., Sanchez-Lopez E., Zárate C.B.Fuentes:scopusKB-R7943 reduces 4-aminopyridine-induced epileptiform activity in adult rats after neuronal damage induced by neonatal monosodium glutamate treatment
ArticleAbstract: Background: Neonatal monosodium glutamate (MSG) treatment triggers excitotoxicity and induces a degePalabras claves:Entorhinal cortex, hippocampus, KB-R7943, Monosodium glutamate, NCX1-3, seizuresAutores:Antoni Camins, Cardenas-Castillo J.A., Gutierrez-Barajas P.E., Hernandez-Ojeda M., Ureña-Guerrero M.E., Zárate C.B.Fuentes:scopusResveratrol: An antiaging drug with potential therapeutic applications in treating diseases
ReviewAbstract: The prevention of aging is one of the most fascinating areas in biomedicine. The first step in the dPalabras claves:Alzheimer’s disease, Parkinson’s Disease, Resveratrol, Sirt1Autores:Antoni Camins, Junyent F., Ortuo-Sahagún D., Pallás M., Rojas-Mayorquín A.E., Verdaguer E., Zárate C.B.Fuentes:scopus